Global and United States Dry Eye Syndrome Market Insights, Forecast to 2027

Publisher Name :
Date: 07-Sep-2021
No. of pages: 148
Inquire Before Buying

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

In this report, we mainly study the drugs and eye drops for dry eye.

Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.

North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.

In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.

Market Analysis and Insights: Global and United States Dry Eye Syndrome Market

This report focuses on global and United States Dry Eye Syndrome market.

In 2020, the global Dry Eye Syndrome market size was US$ 5314 million and it is expected to reach US$ 6992.6 million by the end of 2027, with a CAGR of 4.5% during 2021-2027. In United States the Dry Eye Syndrome market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Dry Eye Syndrome Scope and Market Size

Dry Eye Syndrome market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Dry Eye Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Dry Eye Syndrome market size by players, by Type, and by Distribution Channel, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Artificial Tears

- Anti-inflammatory Drugs

- Others

Segment by Distribution Channel

- Hospital

- Retail Pharmacy

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Allergan

- Alcon

- Novartis

- Santen Pharma

- Johnson & Johnson

- Bausch & Lomb

- Thea pharmaceuticals

- URSAPHARM

- SIMILASAN

- Akorn

- United Laboratories

- Sun Pharmaceutical

- Jianfeng Group

Global and United States Dry Eye Syndrome Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Dry Eye Syndrome Product Introduction
1.2 Market by Type
1.2.1 Global Dry Eye Syndrome Market Size Growth Rate by Type
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Others
1.3 Market by Distribution Channel
1.3.1 Global Dry Eye Syndrome Market Size Growth Rate by Distribution Channel
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dry Eye Syndrome Market Size, Estimates and Forecasts
2.1.1 Global Dry Eye Syndrome Revenue 2016-2027
2.1.2 Global Dry Eye Syndrome Sales 2016-2027
2.2 Global Dry Eye Syndrome, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Dry Eye Syndrome Historical Market Size by Region (2016-2021)
2.3.1 Global Dry Eye Syndrome Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Dry Eye Syndrome Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Dry Eye Syndrome Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Dry Eye Syndrome Sales Forecast by Region (2022-2027)
2.4.2 Global Dry Eye Syndrome Revenue Forecast by Region (2022-2027)
3 Global Dry Eye Syndrome Competitor Landscape by Players
3.1 Global Top Dry Eye Syndrome Manufacturers by Sales
3.1.1 Global Dry Eye Syndrome Sales by Manufacturer (2016-2021)
3.1.2 Global Dry Eye Syndrome Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Dry Eye Syndrome Manufacturers by Revenue
3.2.1 Key Dry Eye Syndrome Manufacturers Covered: Ranking by Revenue
3.2.2 Global Dry Eye Syndrome Revenue by Manufacturers (2016-2021)
3.2.3 Global Dry Eye Syndrome Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Dry Eye Syndrome Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Dry Eye Syndrome Revenue in 2020
3.2.6 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dry Eye Syndrome Price by Manufacturers
3.4 Global Dry Eye Syndrome Manufacturing Base Distribution, Product Types
3.4.1 Dry Eye Syndrome Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dry Eye Syndrome Product Type
3.4.3 Date of International Manufacturers Enter into Dry Eye Syndrome Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Dry Eye Syndrome Market Size by Type (2016-2021)
4.1.1 Global Dry Eye Syndrome Sales by Type (2016-2021)
4.1.2 Global Dry Eye Syndrome Revenue by Type (2016-2021)
4.1.3 Dry Eye Syndrome Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Dry Eye Syndrome Market Size Forecast by Type (2022-2027)
4.2.1 Global Dry Eye Syndrome Sales Forecast by Type (2022-2027)
4.2.2 Global Dry Eye Syndrome Revenue Forecast by Type (2022-2027)
4.2.3 Dry Eye Syndrome Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Distribution Channel (2016-2027)
5.1 Global Dry Eye Syndrome Market Size by Distribution Channel (2016-2021)
5.1.1 Global Dry Eye Syndrome Sales by Distribution Channel (2016-2021)
5.1.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2016-2021)
5.1.3 Dry Eye Syndrome Price by Distribution Channel (2016-2021)
5.2 Dry Eye Syndrome Market Size Forecast by Distribution Channel (2022-2027)
5.2.1 Global Dry Eye Syndrome Sales Forecast by Distribution Channel (2022-2027)
5.2.2 Global Dry Eye Syndrome Revenue Forecast by Distribution Channel (2022-2027)
5.2.3 Global Dry Eye Syndrome Price Forecast by Distribution Channel (2022-2027)
6 United States by Players, Type and Distribution Channel
6.1 United States Dry Eye Syndrome Market Size YoY Growth 2016-2027
6.1.1 United States Dry Eye Syndrome Sales YoY Growth 2016-2027
6.1.2 United States Dry Eye Syndrome Revenue YoY Growth 2016-2027
6.1.3 United States Dry Eye Syndrome Market Share in Global Market 2016-2027
6.2 United States Dry Eye Syndrome Market Size by Players (International and Local Players)
6.2.1 United States Top Dry Eye Syndrome Players by Sales (2016-2021)
6.2.2 United States Top Dry Eye Syndrome Players by Revenue (2016-2021)
6.3 United States Dry Eye Syndrome Historic Market Review by Type (2016-2021)
6.3.1 United States Dry Eye Syndrome Sales Market Share by Type (2016-2021)
6.3.2 United States Dry Eye Syndrome Revenue Market Share by Type (2016-2021)
6.3.3 United States Dry Eye Syndrome Price by Type (2016-2021)
6.4 United States Dry Eye Syndrome Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Dry Eye Syndrome Sales Forecast by Type (2022-2027)
6.4.2 United States Dry Eye Syndrome Revenue Forecast by Type (2022-2027)
6.4.3 United States Dry Eye Syndrome Price Forecast by Type (2022-2027)
6.5 United States Dry Eye Syndrome Historic Market Review by Distribution Channel (2016-2021)
6.5.1 United States Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
6.5.2 United States Dry Eye Syndrome Revenue Market Share by Distribution Channel (2016-2021)
6.5.3 United States Dry Eye Syndrome Price by Distribution Channel (2016-2021)
6.6 United States Dry Eye Syndrome Market Estimates and Forecasts by Distribution Channel (2022-2027)
6.6.1 United States Dry Eye Syndrome Sales Forecast by Distribution Channel (2022-2027)
6.6.2 United States Dry Eye Syndrome Revenue Forecast by Distribution Channel (2022-2027)
6.6.3 United States Dry Eye Syndrome Price Forecast by Distribution Channel (2022-2027)
7 North America
7.1 North America Dry Eye Syndrome Market Size YoY Growth 2016-2027
7.2 North America Dry Eye Syndrome Market Facts & Figures by Country
7.2.1 North America Dry Eye Syndrome Sales by Country (2016-2021)
7.2.2 North America Dry Eye Syndrome Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Dry Eye Syndrome Market Size YoY Growth 2016-2027
8.2 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Region
8.2.1 Asia Pacific Dry Eye Syndrome Sales by Region (2016-2021)
8.2.2 Asia Pacific Dry Eye Syndrome Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Dry Eye Syndrome Market Size YoY Growth 2016-2027
9.2 Europe Dry Eye Syndrome Market Facts & Figures by Country
9.2.1 Europe Dry Eye Syndrome Sales by Country (2016-2021)
9.2.2 Europe Dry Eye Syndrome Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Dry Eye Syndrome Market Size YoY Growth 2016-2027
10.2 Latin America Dry Eye Syndrome Market Facts & Figures by Country
10.2.1 Latin America Dry Eye Syndrome Sales by Country (2016-2021)
10.2.2 Latin America Dry Eye Syndrome Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dry Eye Syndrome Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Country
11.2.1 Middle East and Africa Dry Eye Syndrome Sales by Country (2016-2021)
11.2.2 Middle East and Africa Dry Eye Syndrome Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Dry Eye Syndrome Products Offered
12.1.5 Allergan Recent Development
12.2 Alcon
12.2.1 Alcon Corporation Information
12.2.2 Alcon Description and Business Overview
12.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Alcon Dry Eye Syndrome Products Offered
12.2.5 Alcon Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Dry Eye Syndrome Products Offered
12.3.5 Novartis Recent Development
12.4 Santen Pharma
12.4.1 Santen Pharma Corporation Information
12.4.2 Santen Pharma Description and Business Overview
12.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Santen Pharma Dry Eye Syndrome Products Offered
12.4.5 Santen Pharma Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Johnson & Johnson Dry Eye Syndrome Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Bausch & Lomb
12.6.1 Bausch & Lomb Corporation Information
12.6.2 Bausch & Lomb Description and Business Overview
12.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bausch & Lomb Dry Eye Syndrome Products Offered
12.6.5 Bausch & Lomb Recent Development
12.7 Thea pharmaceuticals
12.7.1 Thea pharmaceuticals Corporation Information
12.7.2 Thea pharmaceuticals Description and Business Overview
12.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Thea pharmaceuticals Dry Eye Syndrome Products Offered
12.7.5 Thea pharmaceuticals Recent Development
12.8 URSAPHARM
12.8.1 URSAPHARM Corporation Information
12.8.2 URSAPHARM Description and Business Overview
12.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.8.4 URSAPHARM Dry Eye Syndrome Products Offered
12.8.5 URSAPHARM Recent Development
12.9 SIMILASAN
12.9.1 SIMILASAN Corporation Information
12.9.2 SIMILASAN Description and Business Overview
12.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.9.4 SIMILASAN Dry Eye Syndrome Products Offered
12.9.5 SIMILASAN Recent Development
12.10 Akorn
12.10.1 Akorn Corporation Information
12.10.2 Akorn Description and Business Overview
12.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Akorn Dry Eye Syndrome Products Offered
12.10.5 Akorn Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Dry Eye Syndrome Products Offered
12.11.5 Allergan Recent Development
12.12 Sun Pharmaceutical
12.12.1 Sun Pharmaceutical Corporation Information
12.12.2 Sun Pharmaceutical Description and Business Overview
12.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sun Pharmaceutical Products Offered
12.12.5 Sun Pharmaceutical Recent Development
12.13 Jianfeng Group
12.13.1 Jianfeng Group Corporation Information
12.13.2 Jianfeng Group Description and Business Overview
12.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jianfeng Group Products Offered
12.13.5 Jianfeng Group Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Dry Eye Syndrome Industry Trends
13.2 Dry Eye Syndrome Market Drivers
13.3 Dry Eye Syndrome Market Challenges
13.4 Dry Eye Syndrome Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dry Eye Syndrome Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Dry Eye Syndrome Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Artificial Tears
Table 3. Major Manufacturers of Anti-inflammatory Drugs
Table 4. Major Manufacturers of Others
Table 5. Global Dry Eye Syndrome Market Size Growth Rate by Distribution Channel (2021-2027) & (M Units)
Table 6. Global Dry Eye Syndrome Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Dry Eye Syndrome Sales by Regions (2016-2021) & (M Units)
Table 8. Global Dry Eye Syndrome Sales Market Share by Regions (2016-2021)
Table 9. Global Dry Eye Syndrome Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Dry Eye Syndrome Sales Forecast by Region (2022-2027) & (M Units)
Table 11. Global Dry Eye Syndrome Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Dry Eye Syndrome Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Dry Eye Syndrome Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Dry Eye Syndrome Sales by Manufacturers (2016-2021) (M Units)
Table 15. Global Dry Eye Syndrome Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Dry Eye Syndrome Manufacturers by Revenue (US$ Million) in 2020
Table 17. Dry Eye Syndrome Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Dry Eye Syndrome Revenue Share by Manufacturers (2016-2021)
Table 19. Global Dry Eye Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Dry Eye Syndrome by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Syndrome as of 2020)
Table 21. Key Manufacturers Dry Eye Syndrome Price (2016-2021) (US$/Unit)
Table 22. Dry Eye Syndrome Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Dry Eye Syndrome Product Type
Table 24. Date of International Manufacturers Enter into Dry Eye Syndrome Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Dry Eye Syndrome Sales by Type (2016-2021) (M Units)
Table 27. Global Dry Eye Syndrome Sales Share by Type (2016-2021)
Table 28. Global Dry Eye Syndrome Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Dry Eye Syndrome Revenue Share by Type (2016-2021)
Table 30. Dry Eye Syndrome Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Dry Eye Syndrome Sales Forecast by Type (2022-2027) & (M Units)
Table 32. Global Dry Eye Syndrome Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Dry Eye Syndrome Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Dry Eye Syndrome Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Dry Eye Syndrome Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Dry Eye Syndrome Sales by Distribution Channel (2016-2021) (M Units)
Table 37. Global Dry Eye Syndrome Sales Share by Distribution Channel (2016-2021)
Table 38. Global Dry Eye Syndrome Revenue by Distribution Channel (2016-2021) (US$ Million)
Table 39. Global Dry Eye Syndrome Revenue Share by Distribution Channel (2016-2021)
Table 40. Dry Eye Syndrome Average Selling Price (ASP) by Distribution Channel (2016-2021) & (US$/Unit)
Table 41. Global Dry Eye Syndrome Sales Forecast by Distribution Channel (2022-2027) & (M Units)
Table 42. Global Dry Eye Syndrome Sales Market Share Forecast by Distribution Channel (2022-2027)
Table 43. Global Dry Eye Syndrome Revenue Forecast by Distribution Channel (2022-2027) & (US$ Million)
Table 44. Global Dry Eye Syndrome Revenue Market Share Forecast by Distribution Channel (2022-2027)
Table 45. Global Dry Eye Syndrome Average Selling Price (ASP) Forecast by Distribution Channel (2022-2027) & (US$/Unit)
Table 46. United States Dry Eye Syndrome Sales (M Units) of Key Companies (2016-2021)
Table 47. United States Dry Eye Syndrome Sales Share by Company (2016-2021)
Table 48. United States Dry Eye Syndrome Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Dry Eye Syndrome Revenue Share by Company (2016-2021)
Table 50. United States Dry Eye Syndrome Sales (M Units) by Type (2016-2021)
Table 51. United States Dry Eye Syndrome Sales Share by Type (2016-2021)
Table 52. United States Dry Eye Syndrome Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Dry Eye Syndrome Price (US$/Unit) by Type (2016-2021)
Table 54. United States Dry Eye Syndrome Sales (M Units) by Type (2022-2027)
Table 55. United States Dry Eye Syndrome Sales Share by Type (2022-2027)
Table 56. United States Dry Eye Syndrome Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Dry Eye Syndrome Revenue Share by Type (2022-2027)
Table 58. United States Dry Eye Syndrome Price (US$/Unit) by Type (2022-2027)
Table 59. United States Dry Eye Syndrome Sales (M Units) by Distribution Channel (2016-2021)
Table 60. United States Dry Eye Syndrome Sales Share by Distribution Channel (2016-2021)
Table 61. United States Dry Eye Syndrome Revenue (US$ Million) Market Share by Distribution Channel (2016-2021)
Table 62. United States Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2016-2021)
Table 63. United States Dry Eye Syndrome Sales (M Units) by Distribution Channel (2022-2027)
Table 64. United States Dry Eye Syndrome Sales Share by Distribution Channel (2022-2027)
Table 65. United States Dry Eye Syndrome Revenue (US$ Million) Market Share by Distribution Channel (2022-2027)
Table 66. United States Dry Eye Syndrome Revenue Share by Distribution Channel (2022-2027)
Table 67. United States Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2022-2027)
Table 68. North America Dry Eye Syndrome Sales by Country (2016-2021) & (M Units)
Table 69. North America Dry Eye Syndrome Sales Market Share by Country (2016-2021)
Table 70. North America Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Dry Eye Syndrome Sales by Region (2016-2021) & (M Units)
Table 73. Asia Pacific Dry Eye Syndrome Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Dry Eye Syndrome Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Dry Eye Syndrome Revenue Market Share by Region (2016-2021)
Table 76. Europe Dry Eye Syndrome Sales by Country (2016-2021) & (M Units)
Table 77. Europe Dry Eye Syndrome Sales Market Share by Country (2016-2021)
Table 78. Europe Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
Table 80. Latin America Dry Eye Syndrome Sales by Country (2016-2021) & (M Units)
Table 81. Latin America Dry Eye Syndrome Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Dry Eye Syndrome Sales by Country (2016-2021) & (M Units)
Table 85. Middle East and Africa Dry Eye Syndrome Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
Table 88. Allergan Corporation Information
Table 89. Allergan Description and Business Overview
Table 90. Allergan Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Allergan Dry Eye Syndrome Product
Table 92. Allergan Recent Development
Table 93. Alcon Corporation Information
Table 94. Alcon Description and Business Overview
Table 95. Alcon Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Alcon Product
Table 97. Alcon Recent Development
Table 98. Novartis Corporation Information
Table 99. Novartis Description and Business Overview
Table 100. Novartis Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Novartis Product
Table 102. Novartis Recent Development
Table 103. Santen Pharma Corporation Information
Table 104. Santen Pharma Description and Business Overview
Table 105. Santen Pharma Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Santen Pharma Product
Table 107. Santen Pharma Recent Development
Table 108. Johnson & Johnson Corporation Information
Table 109. Johnson & Johnson Description and Business Overview
Table 110. Johnson & Johnson Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Johnson & Johnson Product
Table 112. Johnson & Johnson Recent Development
Table 113. Bausch & Lomb Corporation Information
Table 114. Bausch & Lomb Description and Business Overview
Table 115. Bausch & Lomb Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Bausch & Lomb Product
Table 117. Bausch & Lomb Recent Development
Table 118. Thea pharmaceuticals Corporation Information
Table 119. Thea pharmaceuticals Description and Business Overview
Table 120. Thea pharmaceuticals Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Thea pharmaceuticals Product
Table 122. Thea pharmaceuticals Recent Development
Table 123. URSAPHARM Corporation Information
Table 124. URSAPHARM Description and Business Overview
Table 125. URSAPHARM Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. URSAPHARM Product
Table 127. URSAPHARM Recent Development
Table 128. SIMILASAN Corporation Information
Table 129. SIMILASAN Description and Business Overview
Table 130. SIMILASAN Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. SIMILASAN Product
Table 132. SIMILASAN Recent Development
Table 133. Akorn Corporation Information
Table 134. Akorn Description and Business Overview
Table 135. Akorn Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Akorn Product
Table 137. Akorn Recent Development
Table 138. United Laboratories Corporation Information
Table 139. United Laboratories Description and Business Overview
Table 140. United Laboratories Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. United Laboratories Product
Table 142. United Laboratories Recent Development
Table 143. Sun Pharmaceutical Corporation Information
Table 144. Sun Pharmaceutical Description and Business Overview
Table 145. Sun Pharmaceutical Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Sun Pharmaceutical Product
Table 147. Sun Pharmaceutical Recent Development
Table 148. Jianfeng Group Corporation Information
Table 149. Jianfeng Group Description and Business Overview
Table 150. Jianfeng Group Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. Jianfeng Group Product
Table 152. Jianfeng Group Recent Development
Table 153. Dry Eye Syndrome Market Trends
Table 154. Dry Eye Syndrome Market Drivers
Table 155. Dry Eye Syndrome Market Challenges
Table 156. Dry Eye Syndrome Market Restraints
Table 157. Dry Eye Syndrome Customers List
Table 158. Dry Eye Syndrome Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Syndrome Product Picture
Figure 2. Global Dry Eye Syndrome Sales Market Share by Type in 2020 & 2027
Figure 3. Artificial Tears Product Picture
Figure 4. Anti-inflammatory Drugs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dry Eye Syndrome Sales Market Share by Distribution Channel in 2020 & 2027
Figure 7. Hospital
Figure 8. Retail Pharmacy
Figure 9. Others
Figure 10. Dry Eye Syndrome Report Years Considered
Figure 11. Global Dry Eye Syndrome Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dry Eye Syndrome Market Size 2016-2027 (US$ Million)
Figure 13. Global Dry Eye Syndrome Sales 2016-2027 (M Units)
Figure 14. Global Dry Eye Syndrome Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Dry Eye Syndrome Sales Market Share by Region (2016-2021)
Figure 16. Global Dry Eye Syndrome Sales Market Share by Region in 2020
Figure 17. Global Dry Eye Syndrome Revenue Market Share by Region (2016-2021)
Figure 18. Global Dry Eye Syndrome Revenue Market Share by Region in 2020
Figure 19. Global Dry Eye Syndrome Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Dry Eye Syndrome Revenue in 2020
Figure 21. Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Dry Eye Syndrome Sales Market Share by Type (2016-2021)
Figure 23. Global Dry Eye Syndrome Sales Market Share by Type in 2020
Figure 24. Global Dry Eye Syndrome Revenue Market Share by Type (2016-2021)
Figure 25. Global Dry Eye Syndrome Revenue Market Share by Type in 2020
Figure 26. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
Figure 27. Global Dry Eye Syndrome Sales Market Share by Distribution Channel in 2020
Figure 28. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2016-2021)
Figure 29. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel in 2020
Figure 30. United States Dry Eye Syndrome Sales Growth Rate 2016-2027 (M Units)
Figure 31. United States Dry Eye Syndrome Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. United States Dry Eye Syndrome Market Share in Global Market 2016-2027
Figure 33. United States 5 and 10 Largest Dry Eye Syndrome Players Market Share by Revenue in Dry Eye Syndrome in 2020
Figure 34. United States Dry Eye Syndrome Revenue Share by Type (2016-2021)
Figure 35. United States Dry Eye Syndrome Revenue Growth Rate by Type in 2016 & 2020
Figure 36. United States Dry Eye Syndrome Revenue Share by Distribution Channel (2016-2021)
Figure 37. United States Dry Eye Syndrome Revenue Growth Rate by Distribution Channel in 2016 & 2020
Figure 38. North America Dry Eye Syndrome Sales Growth Rate 2016-2021 (M Units)
Figure 39. North America Dry Eye Syndrome Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Dry Eye Syndrome Sales Market Share by Country in 2020
Figure 41. North America Dry Eye Syndrome Revenue Market Share by Country in 2020
Figure 42. United States Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 43. United States Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 45. Canada Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Dry Eye Syndrome Sales Growth Rate 2016-2021 (M Units)
Figure 47. Europe Dry Eye Syndrome Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Dry Eye Syndrome Sales Market Share by Country in 2020
Figure 49. Europe Dry Eye Syndrome Revenue Market Share by Country in 2020
Figure 50. Germany Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 51. Germany Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 53. France Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 55. U.K. Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 57. Italy Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 59. Russia Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Dry Eye Syndrome Sales Growth Rate 2016-2021 (M Units)
Figure 61. Asia Pacific Dry Eye Syndrome Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Dry Eye Syndrome Sales Market Share by Region in 2020
Figure 63. Asia Pacific Dry Eye Syndrome Revenue Market Share by Region in 2020
Figure 64. China Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 65. China Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 67. Japan Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 69. South Korea Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 71. India Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 73. Australia Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 75. China Taiwan Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 77. Indonesia Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 79. Thailand Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Dry Eye Syndrome Sales Growth Rate (2016-2021) (M Units)
Figure 81. Malaysia Dry Eye Syndrome Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America Dry Eye Syndrome Sales Growth Rate 2016-2021 (M Units)
Figure 83. Latin America Dry Eye Syndrome Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America Dry Eye Syndrome Sales Market Share by Country in 2020
Figure 85. Latin America Dry Eye Syndrome Revenue Market Share
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs